Relay Therapeutics (RLAY) EBT (2019 - 2026)
Relay Therapeutics' (RLAY) quarterly EBT came in at -$79.1 million in Q1 2026, down 1.49% year-on-year from -$80.3 million in Q1 2025, and down 125.53% on a QoQ basis from -$35.1 million in Q4 2025.
Relay Therapeutics (RLAY) EBT (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 8 years of EBT data on file, last reported at -$79.1 million in Q1 2026.
- On a quarterly basis, EBT fell 1.49% year-over-year to -$79.1 million in Q1 2026; TTM through Mar 2026 was -$262.4 million, a 64.77% increase from a year earlier, with the FY2025 full-year figure at -$756.2 million, up 1.75% from the prior year.
- EBT for Q1 2026 stood at -$79.1 million, down from -$35.1 million in the prior quarter.
- Over the last five years, EBT for RLAY reached as high as -$35.1 million in Q4 2025 and fell as low as -$484.9 million in Q4 2024.
- Historically, EBT has averaged -$105.8 million across 5 years, with a median of -$82.7 million in 2024.
- Across the five-year window, EBT plunged 443.15% in 2024 and surged 92.76% in 2025, its largest moves.
- Year by year, EBT stood at -$75.1 million in 2022, then dropped by 18.93% to -$89.3 million in 2023, then plunged by 443.15% to -$484.9 million in 2024, then jumped by 92.76% to -$35.1 million in 2025, then sank by 125.53% to -$79.1 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$79.1 million in Q1 2026, -$35.1 million in Q4 2025, and -$74.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Relay Therapeutics | 3.31 Bn | 3.31 Bn | - | -79.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.13 Mn |
| Dec 31, 2025 | -35.09 Mn |
| Sep 30, 2025 | -74.22 Mn |
| Jun 30, 2025 | -73.98 Mn |
| Mar 31, 2025 | -77.97 Mn |
| Dec 31, 2024 | -484.87 Mn |
| Sep 30, 2024 | -88.39 Mn |
| Jun 30, 2024 | -93.56 Mn |
| Mar 31, 2024 | -82.71 Mn |
| Dec 31, 2023 | -89.27 Mn |
| Sep 30, 2023 | -74.27 Mn |
| Jun 30, 2023 | -112.41 Mn |
| Mar 31, 2023 | -100.57 Mn |
| Dec 31, 2022 | -75.06 Mn |
| Sep 30, 2022 | -85.28 Mn |
| Jun 30, 2022 | -92.41 Mn |
| Mar 31, 2022 | -80.07 Mn |
| Dec 31, 2021 | -73.44 Mn |
| Sep 30, 2021 | -61.92 Mn |
| Jun 30, 2021 | -193.74 Mn |